Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Induction Immunochemotherapy in Stage III-IVa Cancer of Oropharynx, Hypopharynx and Larynx

NCT05551767 is registered in ClinicalTrials.gov with City Clinical Oncology Hospital No 1 as lead sponsor.

NCT NCT05551767
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05551767 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Induction Immunochemotherapy in Stage III-IVa Cancer of Oropharynx, Hypopharynx and Larynx
Lead sponsor
City Clinical Oncology Hospital No 1
Phase
Phase 2
Overall status
Unknown status
Start date
August 30, 2022
Completion date
December 30, 2024
Enrollment
120 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

neck cancer